Providing adequate coverage of HIV prevention commodities and services to higher risk populations is a critical component of an effective response to the HIV epidemic in India. To progress this goal, The Fenway Institute has partnered with the Johns Hopkins …
PITTSBURGH, August 12, 2020 – Men at particular risk for HIV are very likely to consistently take prevention medication during vacations when their odds of contracting the virus are higher, according to a new study led by scientists at the …
DURHAM, N.C. – Researchers from the HIV Prevention Trials Network (HPTN) announced today that the HPTN 083 clinical trial showed that a pre-exposure prophylaxis (PrEP) regimen containing long-acting cabotegravir (CAB LA) injected once every 8 weeks was superior to daily …
Boston, MA, May 18 2020 – Today ViiV Healthcare announced the interim analysis of the HIV Prevention Trials Network (HPTN) 083 study evaluating the safety and efficacy of investigational, long-acting, injectable cabotegravir for HIV prevention. In the study, cabotegravir was …
BOSTON, April 3, 2020—A new study published today in the journal Pediatrics found that high rates of HIV transmission among transgender youth may be reduced through interventions that include training on how to provide gender-affirming care for health care practitioners …
In the United States, sexual minority men (SMM) – which includes gay and bisexual men, as well as other men who have sex with men (MSM) – are disproportionately affected by HIV. A new paper examines how effective various behavioral …
The National LGBT Health Education Center at The Fenway Institute is pleased to announce the launch of its PrEP ECHO program, a national online learning collaborative supported by HRSA’s Bureau of Primary Health Care, that uses the groundbreaking ECHO model …
We are pleased to announce that Dr. Kenneth Mayer, Co‑Chair and Medical Research Director at The Fenway Institute, was presented with a Lifetime Achievement Award for HIV Prevention Research from the AIDS Society of India at the ASICON annual meeting…
Boston, MA, September 30, 2019—A groundbreaking study from The Fenway Institute published in the most recent issue of Journal of the international AIDS Society is the first to investigate the use of pre‐exposure prophylaxis (PrEP) and the risk behaviors …
On September 26, we were pleased to host Dr. Sunil Suhas Solomon, Associate Professor of Medicine at John Hopkins University. Dr. Solomon presented recent findings on HIV interventions among key populations in India.
There are an estimated 2.35 million Indian …
